Current Research into Cures for Type-1 Diabetes

Here is another collection of news from the last few weeks. Teplizumab (by MacroGenics / Eli Lilly) Fails in phase-III Trials It appea...

An Encapsulated Human Islet Transplant Cure in Phase-I For the last many years, I have thought that LCT was the only company actively doing...

Two pieces of news from MacroGenics: First, their phase-II human trial of teplizumab (called PROTEGE ) is fully enrolled. Second, they are s...